Cargando…
Rottlerin and Cancer: Novel Evidence and Mechanisms
Because cancers are caused by deregulation of hundreds of genes, an ideal anticancer agent should target multiple gene products or signaling pathways simultaneously. Recently, extensive research has addressed the chemotherapeutic potential of plant-derived compounds. Among the ever-increasing list o...
Autores principales: | Maioli, E., Torricelli, C., Valacchi, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific World Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259573/ https://www.ncbi.nlm.nih.gov/pubmed/22272173 http://dx.doi.org/10.1100/2012/350826 |
Ejemplares similares
-
Alternative Pathways of Cancer Cell Death by Rottlerin: Apoptosis versus Autophagy
por: Torricelli, Claudia, et al.
Publicado: (2012) -
Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells
por: Daveri, Elena, et al.
Publicado: (2015) -
Critical Appraisal of the MTT Assay in the Presence of Rottlerin and Uncouplers
por: Maioli, Emanuela, et al.
Publicado: (2009) -
Rottlerin Inhibits ROS Formation and Prevents NFκB Activation in MCF-7 and HT-29 Cells
por: Maioli, Emanuela, et al.
Publicado: (2009) -
Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma
por: Zhu, Yi, et al.
Publicado: (2017)